Rachel McArthur

The clinical content and technology company has announced a multi-year partnership with leading Saudi hospital information system, OASIS.

Both parties will reportedly collaborate on joint ideas and research in data and artificial intelligence, build a centre for “innovation and knowledge”, and develop related training programmes.

New three-year partnership aims to raise awareness of disorders such as obstructive sleep apnea, as well as provide tailored “integrated, diagnostic and therapeutic” solutions through a Sleep Disorders Management service.

New partnership is part of the UAE capital’s “rapid transformation of the healthcare and technology sectors,” in order to improve patient care.

In the coming months, the Dubai-based airline will work with the DHA to link IT systems of approved laboratories with the airline’s reservations and check-in systems. 

While Lebanon’s portal is already live and reportedly already receiving registrations, Egypt’s website is live but has not yet welcomed sign-ups.

Vaccines by six developers – Sinopharm, Sinovac, Pfizer-BioNTech, Moderna, Oxford-AstraZeneca, and Sputnik V (Gamaleya Research Institute) – are the ones doing the rounds in the region. Here’s what’s known about them.

There are four main types of vaccines currently approved, in approval or being considered in the MENA region in its fight against COVID-19. We bring you a summary of just what they are, how they differ, along with the advantages and disadvantages of each type.

Developed and managed by Pure Health, the Ministry of Health and Prevention’s Riayati aims to provide a centralised medical record for “every citizen and resident” in the Gulf country.

Launched in partnership with the UAE capital’s Department of Health, the platform will use “advanced artificial intelligence analytic technologies such as machine learning” to assess various risk factors.